AB1717 GUIDANCE FOR STEM CELL THERAPY FOR JUVENILE SYSTEMIC SCLEROSIS PATIENTS
Ivan Foeldvari(Center for Rheumatology), Vanessa Smith(Ghent University Hospital), Clarissa Pilkington(Great Ormond Street Hospital), Paulina Horvei(University of Pittsburgh), Kim Fligelstone(Scleroderma and Raynaud's UK), Maurizio Cutolo(Ospedale Policlinico San Martino), Bernd Hinrichs(Asklepios Fachklinikum Brandenburg), S. Li(Hackensack University Medical Center), Clare Pain(University of Toronto), P. Moinzadeh(University Hospital Cologne), Megan L. Curran, F. Roser(Children's Hospital of Pittsburgh), João Silva(Great Ormond Street Hospital), T. Constantin(Semmelweis University), Christopher P. Denton(The Royal Free Hospital), Catherine H. Orteu(Royal Free London NHS Foundation Trust), S. Maillard(Great Ormond Street Hospital), Linda Schraven, J. Henes(Universitätsklinikum Tübingen), Kathryn S. Torok(University of Pittsburgh Medical Center)
Cited by 0
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
Long-term Psychological and Occupational Effects of Providing Hospital Healthcare during SARS Outbreak
|Emerging infectious diseases|2006|1.2k
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699